Oncology

ISO Med : committed to the fight against cancer

Oncology – cancer is one of the first mortality cause in the world.

Every year, more than 7.5 million people die from cancer in the world. Almost 300,000 new cases are diagnosed every year in France, and 450,000 in Germany. Cancer is the cause of nearly 1 million hospitalizations a year in France.

Treatments are more and more costly

Cancer treatment is more and more efficient, but it constitutes one of the first causes of health expenditure in developed countries. In the United States for example, the annual medical expenditure for cancer care is around 90 billion dollars. These costs are sharply increasing: in France, chemotherapy costs rose by 50% between 1999 and 2004.

ISO Med : committed to the fight against cancer

Through its FB Medical trademark, ISO Med designs and produces medical devices that are used in cancer treatment by chemotherapy (access ports and Huber needles). They aim at facilitating drug injection and at improving the comfort of the patient. Facing with increasing costs of cancer treatment, ISO Med aims at achieving:

• Quality : a level of excellence that is demonstrated by CE mark as well as ISO 9001 and 13485 certifications;
• Cost control: prices as low as possible, in order to treat as many patients as possible..